Agenda - Ethics Symposium - Egypt December 2011

List of Participants









Opening Ceremony: Welcome and Introductions

Dr. Dionisio Herrera, TEPHINET

Dr. Mark White, US CDC


Purpose:  To promote the integration of ethical considerations into pandemic influenza plans and the emergencies plan to improve in the field epidemiology activities in each country.


Objectives of the symposium:

1.  Explore Mediterranean perspectives on public health ethics during an influenza pandemic and emergencies.

2.  Advocate for Eastern Mediterranean values on the global public health stage.


3.  Learn how decisions with ethical implications are currently being made in the E M countries and discuss any current plans that include ethical considerations.


4.  Determine methods for integrating public health ethics into pandemic plans, the emergencies plan and into FETP training curricula, in EM countries.

5.  Establish a social network to foster continued discussions about public health ethics.





Specific Outcomes of the Meeting:

  • Projects to improve country response plans to include ethical considerations in influenza preparedness and response plan, leading to changes in national intervention policies.
  • Pedagogical materials (including case stories collected via narrative techniques) that can be included into epidemiological training and specific projects for improving the training curricula on pandemic response and training.
  • An internet-based social networking platform for participants to continue to discuss public health ethics and related topics in terms of improving policy and training.





Presentation: Introduction to the Epidemiology of H1N1 and Emergencies and Experiences from previous Workshops


Dr. Mark White, US CDC


  • To introduce the current status of the ethics issues in relation with the global H1N1 epidemiological situation and other emergencies to participants.
  • To introduce the current example of emergencies in the region and the ethics impact.





Presentation: Introduction to Ethical Dilemmas in Public Health


Dr. Ghaiath Hussein, King Fahad Medical City-Faculty of Medicine




To introduce the basic ethical dilemmas and questions arising in global public health practice.

Experiences in the EM region





Coffee Break and Group Photo


Panel:How, Why and When do Public Health Ethics Matter in Pandemics and Emergencies?

Facilitator: Dr. Mark White, US CDC, Deputy Director of Science

Dr. Ghaiath Hussein, King Fahad Medical City-Faculty of Medicine

Dr. Peter Bloland, US CDC, Director of Division of Public Health Systems and Workforce Development


Prof. Huda Omer Basaleem, Head, Dept. Community Medicine and Public Health, Aden University


Dr. Eman Abd Elkreem Hassen, FETP Coordinator, MOHP




To provide different perspectives on public health ethical issues that may arise during pandemic planning and implementation, and possible next steps in these situations. 



Lunch Break



Small-Group Working Sessions: Narrative Sharing and Evaluation Session 1  (WS1)

Facilitators: Dr. Dionisio Herrera, Dr. Mark White,  Dr. Jawad Asghar, Dr. Dominic Thomas

Ethics Stories List


Imagine you need to train a new or current FETP fellow or epidemiologist on public health ethics issues. What stories do you tell them so that they can really feel and learn the issues? Identify and share ways in which ethical issues can become personal and personal experiences can be related to ethical issues during H1N1 or emergencies.



Participants will be divided into small groups of 5-6 people each. A facilitator will join each group to guide the process and track time.  We will record the stories and upload them to TEPHINET website to build a shared database.


Questions to Consider:

•     What public health ethics situations have you experienced related to H1N1, another epidemic, or program?

•     What was your role in one situation?

•     Who were the main people affected by the situation and how did they react?

•     What actions were taken by whom to resolve the situation?

•     What was the immediate impact did these actions?  What evidence was there of this impact?




Coffee Break







Day 2-




09:00 - 09:30

Summary Session:Important Points from Day 1 and Overview of Day 2

Dr. Dionisio Herrera


09:30- 10:30

Groups Working Session: Identification of Cultural Weights and Values in  the Eastern Mediterranean in relation to WHO’s Ethics Guidelines (WS2)

Facilitators : Dr. Dionisio Herrera, Dr. Jawad Asghar, Dr. Mark White, Tonya Duhart





•     To introduce participants to the WHO guidance on ethics in pandemic influenza

•     To analyze and identify key similarities and differences for cultural weights on the values for countries in the WPR/SEA regions and to identify Asian values that may not be predominant in the global WHO document.



Participants will be divided into small groups of 5-6 people.  Participants will analyze one to two of the WHO Ethics Guidelines and prepare the similarities and differences to present to the larger group at the end of the session.  One facilitator will join each group to facilitate the discussion and keep time.




10:30- 10:45

Coffee Break

10:45 - 11:30

Presentation:Introduction to PHESIG Social Networking group space on the www.tephinet.orgweb site.

Dr. Dominic Thomas, Professor, Emory University




• To introduce participants to the Web resources developed by TEPHINET for member countries to utilize in developing their programs.

• To introduce participants to a resource to continue dialogue and work toward ethics inclusion once the meeting has ended.



Ideally participants will login to the site and explore it while asking questions as they arise.  Each participant should bring a laptop that can connect to the hotel’s wireless network or share computers with each other.


Questions to Consider:

•     What can we do with this PHESIG group? And, how do we access it? 

•     What social networking tools do we have for on-going work in public health (including ethics)?

•     How do I use these tools?




11:30 - 13:00

Groups Working Session: What do we need to know regarding country/regional progress in addressing ethical considerations relevant to planning and response?

Facilitators : Dr. Mohannad Al Nsour, Dr. Jawad Asghar, Dr, Dominic Thomas, Dr. Dionisio Herrera




To identify how ethical considerations were tackled in the country response plan.


  •  Bring your country’s plan.  
  •  Examples of ethical dilemmas that have arisen during a pandemic.  Discuss any ethical issue addressed in your country plan. Identify key areas where you believe improvement would best be added. 
  • Work with colleagues from your country or others at your table to discuss your situation and gather ideas.


13:00-14:00 Lunch Break

Small Groups Working Session: Challenges to integrate ethics in field epidemiology. 

Facilitators: Dr. Dionisio Herrera, Dr. Mark White, Tony Duhart



Add files